188 related articles for article (PubMed ID: 7523532)
1. Expression of the B7/BB1 activation antigen and its ligand CD28 in T-cell-mediated skin diseases.
Simon JC; Dietrich A; Mielke V; Wuttig C; Vanscheidt W; Linsley PS; Schöpf E; Sterry W
J Invest Dermatol; 1994 Oct; 103(4):539-43. PubMed ID: 7523532
[TBL] [Abstract][Full Text] [Related]
2. B7/BB1 provides an important costimulatory signal for CD3-mediated T lymphocyte proliferation in patients with systemic lupus erythematosus (SLE).
Sfikakis PP; Oglesby R; Sfikakis P; Tsokos GC
Clin Exp Immunol; 1994 Apr; 96(1):8-14. PubMed ID: 7512010
[TBL] [Abstract][Full Text] [Related]
3. T lymphocytes in skin lesions of psoriasis and mycosis fungoides express B7-1: a ligand for CD28.
Nickoloff BJ; Nestle FO; Zheng XG; Turka LA
Blood; 1994 May; 83(9):2580-6. PubMed ID: 7513205
[TBL] [Abstract][Full Text] [Related]
4. The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells.
Koulova L; Clark EA; Shu G; Dupont B
J Exp Med; 1991 Mar; 173(3):759-62. PubMed ID: 1847724
[TBL] [Abstract][Full Text] [Related]
5. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1.
Tan P; Anasetti C; Hansen JA; Melrose J; Brunvand M; Bradshaw J; Ledbetter JA; Linsley PS
J Exp Med; 1993 Jan; 177(1):165-73. PubMed ID: 7678111
[TBL] [Abstract][Full Text] [Related]
6. In situ expression of B7/BB1 on antigen-presenting cells and activated B cells: an immunohistochemical study.
Vandenberghe P; Delabie J; de Boer M; De Wolf-Peeters C; Ceuppens JL
Int Immunol; 1993 Mar; 5(3):317-21. PubMed ID: 7682106
[TBL] [Abstract][Full Text] [Related]
7. A pathway of costimulation that prevents anergy in CD28- T cells: B7-independent costimulation of CD1-restricted T cells.
Behar SM; Porcelli SA; Beckman EM; Brenner MB
J Exp Med; 1995 Dec; 182(6):2007-18. PubMed ID: 7500046
[TBL] [Abstract][Full Text] [Related]
8. Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells.
Abrams JR; Kelley SL; Hayes E; Kikuchi T; Brown MJ; Kang S; Lebwohl MG; Guzzo CA; Jegasothy BV; Linsley PS; Krueger JG
J Exp Med; 2000 Sep; 192(5):681-94. PubMed ID: 10974034
[TBL] [Abstract][Full Text] [Related]
9. Keratinocyte expression of B7-1 in transgenic mice amplifies the primary immune response to cutaneous antigens.
Williams IR; Ort RJ; Kupper TS
Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12780-4. PubMed ID: 7528926
[TBL] [Abstract][Full Text] [Related]
10. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal.
Ranheim EA; Kipps TJ
J Exp Med; 1993 Apr; 177(4):925-35. PubMed ID: 7681471
[TBL] [Abstract][Full Text] [Related]
11. The CD28-B7 costimulatory pathway and its role in autoimmune disease.
Daikh D; Wofsy D; Imboden JB
J Leukoc Biol; 1997 Aug; 62(2):156-62. PubMed ID: 9261329
[TBL] [Abstract][Full Text] [Related]
12. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes.
Azuma M; Cayabyab M; Buck D; Phillips JH; Lanier LL
J Exp Med; 1992 Feb; 175(2):353-60. PubMed ID: 1370679
[TBL] [Abstract][Full Text] [Related]
13. Langerhans' cells in vernal keratoconjunctivitis express the costimulatory molecule B7-2 (CD86), but not B7-1 (CD80).
Abu-El-Asrar AM; Al-Kharashi SA; Al-Mansouri S; Missotten L; Geboes K
Eye (Lond); 2001 Oct; 15(Pt 5):648-54. PubMed ID: 11702979
[TBL] [Abstract][Full Text] [Related]
14. In situ expression of B7 and CD28 receptor families in skin lesions of patients with lupus erythematosus.
Denfeld RW; Kind P; Sontheimer RD; Schöpf E; Simon JC
Arthritis Rheum; 1997 May; 40(5):814-21. PubMed ID: 9153541
[TBL] [Abstract][Full Text] [Related]
15. Functional expression of B7/BB1 on activated T lymphocytes.
Azuma M; Yssel H; Phillips JH; Spits H; Lanier LL
J Exp Med; 1993 Mar; 177(3):845-50. PubMed ID: 7679711
[TBL] [Abstract][Full Text] [Related]
16. The immune response induced in vivo by dendritic cells is dependent on B7-1 or B7-2, but the inhibition of both signals does not lead to tolerance.
Lespagnard L; Mettens P; De Smedt T; Bazin H; Urbain J; Leo O; Moser M
Int Immunol; 1998 Mar; 10(3):295-304. PubMed ID: 9576617
[TBL] [Abstract][Full Text] [Related]
17. B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis.
Liu Z; Geboes K; Hellings P; Maerten P; Heremans H; Vandenberghe P; Boon L; van Kooten P; Rutgeerts P; Ceuppens JL
J Immunol; 2001 Aug; 167(3):1830-8. PubMed ID: 11466409
[TBL] [Abstract][Full Text] [Related]
18. Antibody and B7/BB1-mediated ligation of the CD28 receptor induces tyrosine phosphorylation in human T cells.
Vandenberghe P; Freeman GJ; Nadler LM; Fletcher MC; Kamoun M; Turka LA; Ledbetter JA; Thompson CB; June CH
J Exp Med; 1992 Apr; 175(4):951-60. PubMed ID: 1372649
[TBL] [Abstract][Full Text] [Related]
19. CD28/B7 regulation of anti-CD3-mediated immunosuppression in vivo.
Tang Q; Smith JA; Szot GL; Zhou P; Alegre ML; Henriksen KJ; Thompson CB; Bluestone JA
J Immunol; 2003 Feb; 170(3):1510-6. PubMed ID: 12538715
[TBL] [Abstract][Full Text] [Related]
20. Phorbol-12-myristate-13-acetate-treated human keratinocytes express B7-like molecules that serve a costimulatory role in T-cell activation.
Augustin M; Dietrich A; Niedner R; Kapp A; Schöpf E; Ledbetter JA; Brady W; Linsley PS; Simon JC
J Invest Dermatol; 1993 Mar; 100(3):275-81. PubMed ID: 7680055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
